Sam Slutsky
Stock Analyst at LifeSci Capital
(2.26)
# 2,732
Out of 5,012 analysts
3
Total ratings
66.67%
Success rate
8.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sam Slutsky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Initiates: Outperform | $90 | $70.72 | +27.26% | 1 | Aug 4, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Outperform | $45 → $101 | $87.01 | +16.08% | 1 | Jul 23, 2025 | |
| IFRX InflaRx | Upgrades: Outperform | n/a | $1.38 | - | 1 | Apr 5, 2023 |
Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $70.72
Upside: +27.26%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45 → $101
Current: $87.01
Upside: +16.08%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $1.38
Upside: -